IHH Healthcare’s subsidiary NTK is pressing a major claim against Daiichi Sankyo ahead of a Tokyo District Court verdict on September 10. NTK says Daiichi obstructed its acquisition of Fortis Healthcare shares and is demanding JPY 200 billion in damages, setting up a high-stakes legal outcome.
Malaysia’s IHH Healthcare has asked its largest shareholder, Mitsui & Co., to help start communication with Japanese drugmaker Daiichi Sankyo. The move comes despite ongoing legal disputes in India and Japan tied to damages estimated at about ₹11,800 crore. IHH is seeking a path to talks without pausing the complex cross-border litigation.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
